Alzheimer's disease: insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation
Alzheimer's disease is the most common form of senile dementia, affecting more than 24 million people worldwide. It is characterised pathologically by abnormally high levels of neurofibrillary tangles resulting from the accumulation of tau protein in dead and dying neurons, and by elevated numb...
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London
Imperial College Press
c2013
|
| Schriftenreihe: | Molecular medicine and medicinal chemistry
v. 7 |
| Schlagworte: | |
| Online-Zugang: | FHN01 Volltext |
| Zusammenfassung: | Alzheimer's disease is the most common form of senile dementia, affecting more than 24 million people worldwide. It is characterised pathologically by abnormally high levels of neurofibrillary tangles resulting from the accumulation of tau protein in dead and dying neurons, and by elevated numbers of senile plaques in the cortex and hippocampus of the brain. The major component of senile plaques is a small protein of 39–43 amino acids called amyloid-β (Aβ). Thus far, no treatment has been shown to slow the progression of sporadic and familial Alzheimer's disease. A large body of evidence points, however, to the early Aβ-formed oligomers as the primary toxic species in Alzheimer's disease. A powerful strategy for developing pharmaceutical treatments against Alzheimer's is to elucidate the pathways of oligomer formation and determine the structures of the toxic aggregates. This book provides a panoramic view across recent in vitro and in vivo studies along with state-of-the-art computer simulations, designed to increase the readers' understanding of Aβ oligomerisation and fibril formation. At the same time, the book delves into the pathogenesis of familial and sporadic Alzheimer's disease at the atomic level of detail. Written by leading authors in their respective fields, this book will be valuable to all scientists working on Alzheimer's disease |
| Beschreibung: | xix, 444 p. ill. (some col.) |
| ISBN: | 9781848167551 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV044633500 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 171120s2013 |||| o||u| ||||||eng d | ||
| 020 | |a 9781848167551 |c electronic bk. |9 978-1-84816-755-1 | ||
| 024 | 7 | |a 10.1142/P793 |2 doi | |
| 035 | |a (ZDB-124-WOP)00002897 | ||
| 035 | |a (OCoLC)1012674579 | ||
| 035 | |a (DE-599)BVBBV044633500 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-92 | ||
| 082 | 0 | |a 616.831 |2 22 | |
| 245 | 1 | 0 | |a Alzheimer's disease |b insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation |c editor, Philippe Derreumaux |
| 264 | 1 | |a London |b Imperial College Press |c c2013 | |
| 300 | |a xix, 444 p. |b ill. (some col.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Molecular medicine and medicinal chemistry |v v. 7 | |
| 520 | |a Alzheimer's disease is the most common form of senile dementia, affecting more than 24 million people worldwide. It is characterised pathologically by abnormally high levels of neurofibrillary tangles resulting from the accumulation of tau protein in dead and dying neurons, and by elevated numbers of senile plaques in the cortex and hippocampus of the brain. The major component of senile plaques is a small protein of 39–43 amino acids called amyloid-β (Aβ). Thus far, no treatment has been shown to slow the progression of sporadic and familial Alzheimer's disease. A large body of evidence points, however, to the early Aβ-formed oligomers as the primary toxic species in Alzheimer's disease. A powerful strategy for developing pharmaceutical treatments against Alzheimer's is to elucidate the pathways of oligomer formation and determine the structures of the toxic aggregates. This book provides a panoramic view across recent in vitro and in vivo studies along with state-of-the-art computer simulations, designed to increase the readers' understanding of Aβ oligomerisation and fibril formation. At the same time, the book delves into the pathogenesis of familial and sporadic Alzheimer's disease at the atomic level of detail. Written by leading authors in their respective fields, this book will be valuable to all scientists working on Alzheimer's disease | ||
| 650 | 4 | |a Alzheimer's disease / Molecular aspects | |
| 700 | 1 | |a Derreumaux, Philippe |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781848167544 |
| 856 | 4 | 0 | |u http://www.worldscientific.com/worldscibooks/10.1142/P793#t=toc |x Verlag |z URL des Erstveroeffentlichers |3 Volltext |
| 912 | |a ZDB-124-WOP | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030031472 | ||
| 966 | e | |u http://www.worldscientific.com/worldscibooks/10.1142/P793#t=toc |l FHN01 |p ZDB-124-WOP |q FHN_PDA_WOP |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804178044120727552 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV044633500 |
| collection | ZDB-124-WOP |
| ctrlnum | (ZDB-124-WOP)00002897 (OCoLC)1012674579 (DE-599)BVBBV044633500 |
| dewey-full | 616.831 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.831 |
| dewey-search | 616.831 |
| dewey-sort | 3616.831 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02892nmm a2200373zcb4500</leader><controlfield tag="001">BV044633500</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">171120s2013 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781848167551</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-84816-755-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1142/P793</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-124-WOP)00002897</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1012674579</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044633500</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-92</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.831</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Alzheimer's disease</subfield><subfield code="b">insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation</subfield><subfield code="c">editor, Philippe Derreumaux</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Imperial College Press</subfield><subfield code="c">c2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xix, 444 p.</subfield><subfield code="b">ill. (some col.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Molecular medicine and medicinal chemistry</subfield><subfield code="v">v. 7</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Alzheimer's disease is the most common form of senile dementia, affecting more than 24 million people worldwide. It is characterised pathologically by abnormally high levels of neurofibrillary tangles resulting from the accumulation of tau protein in dead and dying neurons, and by elevated numbers of senile plaques in the cortex and hippocampus of the brain. The major component of senile plaques is a small protein of 39–43 amino acids called amyloid-β (Aβ). Thus far, no treatment has been shown to slow the progression of sporadic and familial Alzheimer's disease. A large body of evidence points, however, to the early Aβ-formed oligomers as the primary toxic species in Alzheimer's disease. A powerful strategy for developing pharmaceutical treatments against Alzheimer's is to elucidate the pathways of oligomer formation and determine the structures of the toxic aggregates. This book provides a panoramic view across recent in vitro and in vivo studies along with state-of-the-art computer simulations, designed to increase the readers' understanding of Aβ oligomerisation and fibril formation. At the same time, the book delves into the pathogenesis of familial and sporadic Alzheimer's disease at the atomic level of detail. Written by leading authors in their respective fields, this book will be valuable to all scientists working on Alzheimer's disease</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Alzheimer's disease / Molecular aspects</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Derreumaux, Philippe</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781848167544</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.worldscientific.com/worldscibooks/10.1142/P793#t=toc</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveroeffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-124-WOP</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030031472</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.worldscientific.com/worldscibooks/10.1142/P793#t=toc</subfield><subfield code="l">FHN01</subfield><subfield code="p">ZDB-124-WOP</subfield><subfield code="q">FHN_PDA_WOP</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV044633500 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T07:57:42Z |
| institution | BVB |
| isbn | 9781848167551 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030031472 |
| oclc_num | 1012674579 |
| open_access_boolean | |
| owner | DE-92 |
| owner_facet | DE-92 |
| physical | xix, 444 p. ill. (some col.) |
| psigel | ZDB-124-WOP ZDB-124-WOP FHN_PDA_WOP |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | Imperial College Press |
| record_format | marc |
| series2 | Molecular medicine and medicinal chemistry |
| spelling | Alzheimer's disease insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation editor, Philippe Derreumaux London Imperial College Press c2013 xix, 444 p. ill. (some col.) txt rdacontent c rdamedia cr rdacarrier Molecular medicine and medicinal chemistry v. 7 Alzheimer's disease is the most common form of senile dementia, affecting more than 24 million people worldwide. It is characterised pathologically by abnormally high levels of neurofibrillary tangles resulting from the accumulation of tau protein in dead and dying neurons, and by elevated numbers of senile plaques in the cortex and hippocampus of the brain. The major component of senile plaques is a small protein of 39–43 amino acids called amyloid-β (Aβ). Thus far, no treatment has been shown to slow the progression of sporadic and familial Alzheimer's disease. A large body of evidence points, however, to the early Aβ-formed oligomers as the primary toxic species in Alzheimer's disease. A powerful strategy for developing pharmaceutical treatments against Alzheimer's is to elucidate the pathways of oligomer formation and determine the structures of the toxic aggregates. This book provides a panoramic view across recent in vitro and in vivo studies along with state-of-the-art computer simulations, designed to increase the readers' understanding of Aβ oligomerisation and fibril formation. At the same time, the book delves into the pathogenesis of familial and sporadic Alzheimer's disease at the atomic level of detail. Written by leading authors in their respective fields, this book will be valuable to all scientists working on Alzheimer's disease Alzheimer's disease / Molecular aspects Derreumaux, Philippe Sonstige oth Erscheint auch als Druck-Ausgabe 9781848167544 http://www.worldscientific.com/worldscibooks/10.1142/P793#t=toc Verlag URL des Erstveroeffentlichers Volltext |
| spellingShingle | Alzheimer's disease insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation Alzheimer's disease / Molecular aspects |
| title | Alzheimer's disease insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation |
| title_auth | Alzheimer's disease insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation |
| title_exact_search | Alzheimer's disease insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation |
| title_full | Alzheimer's disease insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation editor, Philippe Derreumaux |
| title_fullStr | Alzheimer's disease insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation editor, Philippe Derreumaux |
| title_full_unstemmed | Alzheimer's disease insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation editor, Philippe Derreumaux |
| title_short | Alzheimer's disease |
| title_sort | alzheimer s disease insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments molecular basis of amyloid beta protein aggregation and fibril formation |
| title_sub | insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation |
| topic | Alzheimer's disease / Molecular aspects |
| topic_facet | Alzheimer's disease / Molecular aspects |
| url | http://www.worldscientific.com/worldscibooks/10.1142/P793#t=toc |
| work_keys_str_mv | AT derreumauxphilippe alzheimersdiseaseinsightsintolowmolecularweightandcytotoxicaggregatesfrominvitroandcomputerexperimentsmolecularbasisofamyloidbetaproteinaggregationandfibrilformation |